Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical presentation and management of patients with primary hyperparathyroidism in Italy.
Saponaro F, Cetani F, Repaci A, Pagotto U, Cipriani C, Pepe J, Minisola S, Cipri C, Vescini F, Scillitani A, Salcuni A, Palmieri S, Eller-Vainicher C, Chiodini I, Madeo B, Kara E, Castellano E, Borretta G, Gianotti L, Romanelli F, Camozzi V, Faggiano A, Corbetta S, Cianferotti L, Brandi ML, De Feo ML, Palermo A, Vezzoli G, Maino F, Scalese M, Marcocci C. Saponaro F, et al. Among authors: cipri c. J Endocrinol Invest. 2018 Nov;41(11):1339-1348. doi: 10.1007/s40618-018-0879-z. Epub 2018 Apr 3. J Endocrinol Invest. 2018. PMID: 29616419
Mazabraud's Syndrome: A Case Report and Up-To-Date Literature Review.
Vescini F, Falchetti A, Tonelli V, Carpentieri M, Cipri C, Cosso R, Kara E, Triggiani V, Grimaldi F. Vescini F, et al. Among authors: cipri c. Endocr Metab Immune Disord Drug Targets. 2019;19(6):885-893. doi: 10.2174/1871530319666181226103700. Endocr Metab Immune Disord Drug Targets. 2019. PMID: 30585553 Review.
An Unusual Case of Medullary Thyroid Carcinoma and A Revision of Current Literature.
Cipri C, Vescini F, Torresan F, Pennelli G, Pelizzo MR, Triggiani V, Guastamacchia E, Grimaldi F. Cipri C, et al. Endocr Metab Immune Disord Drug Targets. 2019;19(2):226-229. doi: 10.2174/1871530319666181220165350. Endocr Metab Immune Disord Drug Targets. 2019. PMID: 30574858 Free PMC article. Review.
Limited value of repeat recombinant human thyrotropin (rhTSH)-stimulated thyroglobulin testing in differentiated thyroid carcinoma patients with previous negative rhTSH-stimulated thyroglobulin and undetectable basal serum thyroglobulin levels.
Castagna MG, Brilli L, Pilli T, Montanaro A, Cipri C, Fioravanti C, Sestini F, Capezzone M, Pacini F. Castagna MG, et al. Among authors: cipri c. J Clin Endocrinol Metab. 2008 Jan;93(1):76-81. doi: 10.1210/jc.2007-1404. Epub 2007 Oct 30. J Clin Endocrinol Metab. 2008. PMID: 17971424
Shift from Levothyroxine Tablets to Liquid Formulation at Breakfast Improves Quality of Life of Hypothyroid Patients.
Guglielmi R, Grimaldi F, Negro R, Frasoldati A, Misischi I, Graziano F, Cipri C, Guastamacchia E, Triggiani V, Papini E. Guglielmi R, et al. Among authors: cipri c. Endocr Metab Immune Disord Drug Targets. 2018;18(3):235-240. doi: 10.2174/1871530318666180125155348. Endocr Metab Immune Disord Drug Targets. 2018. PMID: 29376496 Free PMC article.
Medullary thyroid carcinoma.
Pacini F, Castagna MG, Cipri C, Schlumberger M. Pacini F, et al. Among authors: cipri c. Clin Oncol (R Coll Radiol). 2010 Aug;22(6):475-85. doi: 10.1016/j.clon.2010.05.002. Clin Oncol (R Coll Radiol). 2010. PMID: 20627492 Review.
A comparison of 1850 (50 mCi) and 3700 MBq (100 mCi) 131-iodine administered doses for recombinant thyrotropin-stimulated postoperative thyroid remnant ablation in differentiated thyroid cancer.
Pilli T, Brianzoni E, Capoccetti F, Castagna MG, Fattori S, Poggiu A, Rossi G, Ferretti F, Guarino E, Burroni L, Vattimo A, Cipri C, Pacini F. Pilli T, et al. Among authors: cipri c. J Clin Endocrinol Metab. 2007 Sep;92(9):3542-6. doi: 10.1210/jc.2007-0225. Epub 2007 Jul 3. J Clin Endocrinol Metab. 2007. PMID: 17609306 Clinical Trial.
31 results